ArticlePharmaceutical biology2022

Catalpol relieved angiotensin II-induced blood-brain barrier destruction via inhibiting the TLR4 pathway in brain endothelial cells.

Yu Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.